Stock

Park Dental Partners, Inc. (NASDAQ: PARK) Lock-Up Expiry — 3 December 2026

What releases, when, and how much normal trading it would take to absorb it.

Data as of 15 November 2026. Expiry ahead.

Shares unlocking 176,852
Value at the latest close $4M at $21.49 a share
Value / market cap 3% of $119M
Absorb days 3.9 normal trading sessions

What releases on 3 December 2026

Expiry date3 December 2026
Trigger, as stated in the filing365 days after prospectus
Shares released176,852
Value at the latest close$4M
Market capitalisation$119M
Value / market cap3%
Absorb days3.9
ExchangeNASDAQ
SectorHealthcare
Offer price$13.00
Listed3 December 2025
Latest close$21.49
Since the offer price+65.3%

How to read the two numbers that matter

Value / market cap measures the unlocking stock against the whole company. Absorb days is sharper: the unlocking shares divided by the stock’s own average daily volume over the last 20 sessions — how many normal trading sessions it would take the market to absorb the supply. A large unlock at a heavily traded company is a rounding error; a small one at a stock that barely trades is not. We mark a lock-up where the value reaches 25% of market capitalisation, or where absorbing it would take 50 sessions or more.

What these numbers do not tell you. An expiry removes a legal restriction; it does not create a seller. Insiders may hold, sell in part, or have sold forward already. Many lock-ups release in stages rather than all at once, and some stages carry a price condition — shares release early only if the stock closes a set percentage above the offer price on a given number of days, so a headline dollar figure can overstate what actually reaches the market. Because the date is known months ahead, the price usually moves before the date rather than on it.

Source. The expiry date, the trigger and the share counts are read from the company’s own SEC filing: SEC filing. Price, market capitalisation and the return since the offer price are as of 15 November 2026. Average daily volume is the last 20 sessions.

iposight.com — for informational purposes only. Nothing on this page is a recommendation to buy or sell.